DalsnaFinance › IPOs › Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on July 18, 2018, pricing at $17.00 a share.
| Ticker | CRNX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 18, 2018 |
| Offering price | $17.00 |
| Shares offered | 6,000,000 |
| Total raised | $102M |
Crinetics Pharmaceuticals, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.